Abstract: Although daily low-intensity pulsed ultrasound (LIPUS) can accelerate osteogenic differentiation of the rat clonal cell line ROS 17/2.8, the molecular mechanism that underlies this phenomenon is unclear. The purpose of this study was to determine which molecules exposed to daily LIPUS treatment stimulate osteogenic differentiation. The cells were cultured in the presence and absence (control) of LIPUS stimulation. LIPUS treatments consisted of 1.5-MHz ultrasound administered at an intensity of 30 mW/cm 2 , 20 min daily for 7 days. The expression of bone morphogenetic proteins (BMPs) and their receptors involved in osteogenesis were measured using realt i m e P C R a n d / o r We s t e rn b l o t a n a l y s i s . 
Introduction
Ultrasound has been used as a therapeutic, diagnostic, and surgical tool for a long time, and low-intensity pulsed ultrasound (LIPUS) stimulation is an established and widely used intervention for accelerating bone growth during fracture healing and distraction osteogenesis (1, 2) . Moreover, LIPUS stimulation has been reported to accelerate bone maturation in animal models (3) and in clinical treatments (4) .
In vitro experiments have demonstrated that LIPUS alters the differentiation pathway of the pluripotent mesenchymal cell line C2C12 into an osteoblast and/or chondroblast lineage (5) , and stimulates osteogenic differentiation in osteoblastic cells (6) . We postulated that the effects of LIPUS treatment may be due to bone morphogenetic protein (BMP)-like molecules. The underlying mechanism responsible for the pronounced effects of daily LIPUS on osteogenesis, however, has not been fully elucidated.
BMPs are unique because they induce the differentiation of mesenchymal cells toward cells of the osteoblastic lineage and also enhance the differentiated function of the Daily low-intensity pulsed ultrasound stimulates production of bone morphogenetic protein in ROS 17/2.8 cells Akito Suzuki 1) , Tadahiro Takayama 2) , Naoto Suzuki 3, 4) , Taro Kojima 2) , Noriko Ota 2) , Shoichi Asano 2) and Koichi Ito Original osteoblast (7, 8) . BMPs bind to specific receptors and signal the cytoplasmic proteins mothers against decapentaplegic (Smad) 1 and 5 via phosphorylation. Smad 1 and 5 then form heterodimers with Smad4; these heterodimers undergo nuclear translocation and subsequently regulate transcription (9) (10) (11) (12) . In addition, the effects of BMPs can be modulated by a large number of secreted proteins that limit BMP action. Extracellular BMP antagonists prevent BMP signaling by binding BMPs, thus precluding their binding to specific cell surface receptors. These antagonists include noggin, chordin, and follistatin, which tend to be specific for, and are regulated by, BMPs, indicating the existence and need for local feedback mechanisms to temper BMP cellular activity (13) (14) (15) (16) .
To obtain insights into daily LIPUS treatment-induced bone formation, we investigated the effects of daily LIPUS treatment on the expression profiles of BMPs, BMP receptors, and phosphorylation of Smad1 in a rat osteosarcoma cell line.
Materials and Methods

Cell culture
We used the rat clonal cell line ROS 17/2.8 (ROS cells) (17) as the osteoblastic cell line. Although ROS cells were established from rat osteosarcoma, numerous studies have used these cells as typical rat osteoblasts or osteoblast-like cells (18) (19) (20) . We therefore assumed that ROS cells represent the osteoblasts of alveolar bone in the periodontium. The cells were maintained in α-minimal essential medium (α-MEM; Gibco BRL, Rockville, MD, USA) containing 10% (v/v) heat-inactivated fetal bovine serum (FBS; HyClone Laboratories, Logan, UT, USA) and 1% (v/v) penicillin-streptomycin solution (Sigma Chemical, St. Louis, MO, USA) at 37°C in a humidified atmosphere of 95% air and 5% CO 2 .
Ultrasound treatment ROS cells at the fifth or sixth passage were transferred into six-well microplates at a density of 2.0 × 10 4 cells/cm 2 . The cells were subjected to daily LIPUS with modifications, as reported previously (21, 22) . Briefly, a sterilized transducer (Asahi Irika Co, Ltd., Saitama, Japan) generating 1.5-MHz LIPUS in a pulsed-wave mode at 30 mW/cm 2 was placed horizontally into each culture well so that it was barely touching the surface of the medium. The distance between the transducer and the cells was 3-4 mm. LIPUS stimulation was performed for 20 min daily up to 7 days, when the cells reached confluence. The culture medium was replaced with fresh medium once every 3 days. Control samples were treated in the same manner, without exposure to LIPUS.
Real-time PCR
ROS cells were plated in six-well microplates at a density of 2.0 × 10 4 cells/cm 2 and cultured for up to 7 days in the presence and absence (control) of LIPUS stimulation. On day 7 of daily LIPUS exposure, total RNA was isolated from the cultured cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Aliquots containing equal amounts of mRNA were subjected to real-time PCR analysis.
The amount of RNA was equalized using a human β-actin competitive PCR kit (Takara Shuzo, Shiga, Japan), and the mRNA was converted into cDNA using an RNA PCR kit (GeneAmp; Perkin-Elmer, Branchburg, NJ, USA). The resultant cDNA mixtures were diluted fivefold in sterile distilled water, and 2 ml was subjected to real-time PCR using SYBR Green I dye (BioWhittaker Molecular Applications, Rockland, ME, USA). The reactions were performed in 25-µl of a solution containing 1 × R-PCR buffer, 1.5 mM dNTP mixture, 1 × SYBR Green I, 15 mM MgCl 2 , 0.25 U Ex Taq R-PCR version (Takara Shuzo), and 20 mM primers (sense and antisense; Table 1 ). The primers were designed using Primer3 software (Whitehead Institute for Biomedical Research, Cambridge, MA, USA).
Assays were performed on a Smart Cycler (Cepheid, Sunnyvale, CA, USA) and analyzed using Smart Cycler software (Ver. 1.2d). The PCR conditions were 95°C for 3 s and 40 cycles at 68°C for 20 s. Measurements were taken at the end of each 68°C annealing step. PCR product specificity was verified by a melting curve analysis between 68 and 94°C. All real-time PCR reactions were performed in triplicate, and the gene expression levels were normalized by dividing the calculated value for the mRNA samples by that for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA at each time point.
Extraction of proteins from the cultured cells
To obtain whole-cell extracts, ROS 17/2.8 cells that had been cultured in the presence and absence (control) of LIPUS treatment were rinsed with phosphate-buffered saline (PBS) and exposed to a lysis buffer consisting of 50 mM Tris-HCl, 0.1% Triton X-100, 0.1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride. The cells were then sonicated three times for 10 s each. Aliquots containing equal amounts of protein were subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE).
SDS-PAGE and Western blotting
Aliquots of the conditioned medium and whole-cell extracts containing equal amounts of protein were analyzed by SDS-PAGE on a 5-20% gradient cross-linked polyacrylamide gel at 150 V for 60 min. The discontinuous Tris-glycine buffer system of Laemmli was used for electrophoresis (23) .
The separated proteins were immunotransferred to a membrane using a semidry transfer unit and a continuous buffer system at 0.8 mA/cm 2 constant amperage for 60-90 min. After the transfer was complete, the transfer membrane was treated with 25% (v/v) blocking reagent at 4°C for 18 h. The membranes were probed with 1:500 dilutions of antibodies against BMP-2, BMP-4, BMP-7, phosphorylated Smad1 (p-Smad1), and tubulin (all from Santa Cruz Biotechnology, Santa Cruz, CA, USA), followed by the addition of biotin-conjugated secondary antibodies (diluted 1:10,000) (24) . The membranes were then treated with horseradish-peroxidase-conjugated streptavidin. Immunoreactive proteins were visualized using a chemiluminescence kit (Amersham LifeScience, Buckinghamshire, UK) with exposure to X-ray film. As a control, the transfer membrane was also exposed to normal rabbit serum at concentrations adjusted to match those of the primary antibodies.
Effect of daily LIPUS on protein and mRNA expression of BMPs and their receptors ROS 17/2.8 cells were plated onto six-well microplates at a density of 2.0 × 10 4 cells/ well, and were then cultured in the presence and absence (control) of LIPUS for up to 7 days.
Effect of daily LIPUS on the phosphorylation of Smad1
ROS 17/2.8 cells were plated onto six-well microplates at a density of 2.0 × 10 4 cells/ well, and were then cultured in the presence and absence (control) of LIPUS for up to 30 min on day 7.
Effect of noggin on daily LIPUS-induced Smad1 phosphorylation ROS 17/2.8 cells in growth medium were plated onto six-well microplates at a density of 2.0 × 10 4 cells/well. The following day, the medium was exchanged for fresh medium and exposed to LIPUS daily, with or without 100 ng/ml noggin (G-T, Minneapolis, MN, USA), after which the cells were incubated for up to 30 min on day 7 (to measure the phosphorylation of Smad1).
Statistical analysis
All data are represented as the mean ± standard deviation (SD). The statistical significance was determined using Bonferroni's modification of Student's t-test. Values of P < 0.05 were considered to be statistically significant.
Results
Effect of daily LIPUS stimulation on BMP-2, -4, and -7 protein expression BMP-2, -4, and -7 protein expression in nuclear extracts of cultured ROS 17/2.8 cells treated with daily LIPUS was examined using western blot analysis. An immunoreactive band was observed at ~17, ~22, and ~20 kDa, which corresponded to BMP-2, -4, and -7, respectively (Fig. 1) . (Fig. 2a-c) .
Of the BMP type II receptors, the cells expressed BMPR-II, ActR-IIA, and ActR-IIB, in the presence and absence (control) of LIPUS treatment. The mRNA expression of those three receptors also increased significantly on day 7 of culture with daily LIPUS (Fig. 2d-f) .
Effects of daily LIPUS on the phosphorylation of Smad1
The phosphorylation of Smad1 was evaluated using western blot analysis. An immunoreactive band at ~65 kDa, which corresponded to phosphorylated Smad1 (p-Smad1), was observed. With the addition of daily LIPUS treatment, the level of p-Smad1 progressively increased after 5-30 min (Fig. 3) .
Effect of noggin on daily LIPUS-induced Smad1 phosphorylation
We used noggin to examine the specificity of the effect of daily LIPUS treatment on the p-Smad1 using Western blot analysis. The addition of 100 ng/ml noggin caused a marked inhibition of the daily LIPUS-induced p-Smad1 (Fig. 4) .
Discussion
The central findings of the present study were that daily LIPUS stimulated osteogenic differentiation via increased BMP production and BMP receptors.
The expression of BMPs, their antagonists, and transcription factors involved in osteogenesis is significantly increased by mechanical stress such as optimal compressive force (25) and shear stress (26) . Although mechanical stress stimulates BMP production, no studies have investigated the effects of daily LIPUS treatment on BMP expression. We previously reported that daily LIPUS stimulation markedly increased the expression of BMP-2 mRNA (27), and we postulated that these effects may be due to BMPs. The hypothesis of the present study was that daily LIPUS treatment would accelerate osteogenic differentiation via BMP expression. Consequently, we extracts from these cells were analyzed using Western blotting. Upper two panels: pSmad1expression; lower two panels: Smad1 expression. The phosphorylation of Smad1 after daily LIPUS treatment was blocked with 100 ng/ml noggin.
investigated the effects of daily LIPUS treatment on BMP expression in detail. BMPs can up-regulate Cbfa1/Runx2 mRNA expression in vitro. BMP-2, -4, and -7 (members of the TGF-β superfamily) are the primary growth factors that promote the differentiation of mesenchymal cells into osteoblasts or chondroblasts (28) . BMP-2 increased Runx2 mRNA expression in an immortalized human bone marrow stromal cell line, hMC2-6 cells (29), C2C12 cells (30) , and 2T3 cells (31) . BMP-4 also stimulated osteoblastic differentiation of the mouse bone marrow stromal cell lines ST2 and MC3T3-G2/PA6 (32) . BMP-7 induced the expression of Runx2 mRNA prior to the induction of osteocalcin mRNA in C3H10T1/2, cells from early mouse embryos (33) . Based on these studies, we examined the effect of daily LIPUS treatment on BMP-2, -4, and -7 protein expression. Our results indicated that daily LIPUS treatment caused a substantial increase in expression of all BMP proteins. These results suggest that daily LIPUS treatment promotes osteogenic differentiation of ROS cells.
As BMP binds specific receptors (33), the effects of daily LIPUS on the expression of BMP receptors were examined. Our results demonstrated that both type I receptors (BMPR-IA, BMPR-IB, and ActR-I) and type II receptors (BMPR-II, ActR-IIA, and ActR-IIB) were significantly increased by daily LIPUS treatment. These results were observed irrespective of their subfamily. In addition, these results suggest that daily LIPUS treatment accelerates the autocrine action of BMPs.
Evidence exists of the autoregulation of BMP expression in osteoblasts, which acts as a negative feedback loop to decrease cellular exposure to BMPs. These protective mechanisms do not appear to be sufficient, and much of the regulation of BMP action occurs through the presence of intercellular and extracellular factors that modulate BMP activity (34) . Numerous antagonists of BMP have been identified, including noggin, follistatin, and chordin (35) . All BMP antagonists share the functional property of specifically binding BMPs to prevent them from interacting with their receptors (35, 36) . Noggin is known to inhibit the functions of BMP-2, BMP-4, and BMP-7 (35) . Thus, in this study, we examined the effect of noggin on the phosphorylation of Smad1. We found that noggin markedly inhibited daily LIPUS-induced phosphorylation of Smad1. These results strongly suggest that the phosphorylation of Smad1 enhanced by daily LIPUS is a result of the autocrine action of daily LIPUS-induced BMP expression.
In conclusion, we showed that daily LIPUS treatment significantly increased the expression of the BMP-2, -4, and -7 proteins and Smad1 phosphorylation, and the phosphorylation of Smad1 can be blocked by the BMP antagonist, noggin. Therefore, osteogenic activity of daily LIPUS may be mediated by BMPs.
